SAN DIEGO, Feb. 22 (GenomeWeb News) - Following a talk at the Clinical Genomics conference here last week, Walter Koch, senior director of Roche's pharmacogenomics department, provided a few details concerning the company's upcoming leukemia microarray and p53 AmpliChip products, which are being produced using technology the company licensed from Affymetrix.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.